PropertyValue
?:abstract
  • The world is now experiencing its third major epidemic of coronavirus (CoV) infections began in Wuhan, Hubei, China, in late 2019 and named COVID-19. After an initial explosive outbreak of pneumonia of unknown etiology in China, the disease spread first to neighboring Asian countries and then worldwide. Patients with COVID-19 presented with a constellation of symptoms such as fever, dry cough, dyspnea, sore throat, and nasal congestion and radiological findings showed bilateral lung glassy opacities. Vitamin D has many mechanisms by which it reduces the risk of microbial infection and death, including physical barrier, cellular natural immunity, and adaptive immunity. Vitamin D supplementation has shown favorable effects in viral infections including influenza and HIV. The effects of vitamin D supplementation during covid 19 infection remain controversial. Looking ahead, clinical studies are needed to define better cut offs for vitamin D levels and, finally, which dosage is the best.
is ?:annotates of
?:creator
?:doi
  • 10.1186/s12948-020-00139-0
?:doi
?:journal
  • Clin_Mol_Allergy
?:license
  • cc-by
?:pdf_json_files
  • document_parses/pdf_json/3353f8e7ac83e2a84bbc53f3d59f2e55e54c35c1.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7675394.xml.json
?:pmcid
?:pmid
?:pmid
  • 33292313.0
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:sha_id
?:source
  • Medline; PMC
?:title
  • Vitamin D and Covid-19: an update on evidence and potential therapeutic implications
?:type
?:year
  • 2020-11-19

Metadata

Anon_0  
expand all